Marc M. Snijders

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

The impact of the patient macroenvironment on molecular subgroups in endometrial cancer.

The impact of the patient macroenvironment on molecular subgroups in endometrial cancer.

Journal: Cancer

Published: December 10, 2025

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 06, 2025

Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?

Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?

Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Published: January 08, 2024

Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.

Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.

Journal: Gynecologic oncology

Published: December 04, 2023

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer.

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer.

Journal: Cancers

Published: February 28, 2023

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.

Journal: JAMA network open

Published: December 16, 2022

Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer.

Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 17, 2022

Pure and mixed clear cell carcinoma of the endometrium: A molecular and immunohistochemical analysis study.

Pure and mixed clear cell carcinoma of the endometrium: A molecular and immunohistochemical analysis study.

Journal: Cancer medicine

Published: October 13, 2022

Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.

Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.

Journal: American journal of obstetrics and gynecology

Published: February 05, 2021

The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study.

The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study.

Journal: Human pathology

Published: October 11, 2020

Fallopian tube abnormalities in uterine serous carcinoma.

Fallopian tube abnormalities in uterine serous carcinoma.

Journal: Gynecologic oncology

Published: March 27, 2020

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.

Journal: International journal of cancer

Published: January 02, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026